AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Laviceftra S 500mg/250mg Injection

Prescription Icon
Prescription Required

Marketer

Lavish Biotech

Salt Composition

Ceftriaxone (500mg) + Sulbactam (250mg)

Overview Laviceftra S 500mg/250mg Injection

Ceftolozane/Tazobactam 500mg/250mg Injection is a dual-action antibiotic. It's used to combat a range of bacterial infections by inhibiting microbial growth and propagation. Administration must be overseen by a medical professional. Strict adherence to the prescribed dosage schedule is crucial; complete the full course, regardless of symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and upset stomach. Worsening side effects necessitate immediate medical attention. Seek emergency care for allergic reactions (skin rashes, itching, swelling, breathing difficulties). Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While it generally doesn't affect driving ability, refrain from driving if experiencing drowsiness or dizziness. Adequate rest, a nutritious diet, and sufficient hydration are recommended for optimal recovery. Your doctor may order blood tests and other assessments to monitor treatment response.

Uses of Laviceftra S 500mg/250mg Injection

Infections caused by bacteria

Major Benefits of Laviceftra S 500mg/250mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

Common Side effects of Laviceftra S 500mg/250mg Injection:

  • Increased white blood cell count (eosinophils)
  • Decreased white blood cell count (lymphocytes)
  • Low blood platelets
  • Rash
  • Diarrhea
  • Increased liver enzymes
  • Injection site reactions (pain, swelling, redness)

How to use Laviceftra S 500mg/250mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Laviceftra S 500mg/250mg Injection works:

Ceftriaxone/Sulbactam 500mg/250mg (Laviceftra S Injection) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam counters bacterial resistance, thereby optimizing Ceftriaxone's antibacterial effect.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse reactions associated with the concomitant use of alcohol and Laviceftra S 500mg/250mg Injection.

PregnancyPregnancySAFE IF PRESCRIBED

The injectable medication Laviceftra S 500mg/250mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; however, clinical data in humans are scarce.

Breast feedingBreast feedingCAUTION

Administering Laviceftra S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.

DrivingDrivingUNSAFE

The administration of Laviceftra S 500mg/250mg Injection can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneyCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Laviceftra S 500mg/250mg Injection to individuals with impaired renal function. Physician consultation is advised.

LiverLiverCAUTION

Patients with severe hepatic impairment should use Laviceftra S 500mg/250mg Injection cautiously, potentially requiring dosage modification. Consult a physician for guidance. Dosage alterations for Laviceftra S 500mg/250mg Injection are unnecessary for individuals with mild or moderate liver dysfunction.

What if you forget to take Laviceftra S 500mg/250mg Injection :

Omitting a scheduled dose of Laviceftra S 500mg/250mg Injection warrants immediate physician consultation.

Facts to Know About Laviceftra S 500mg/250mg Injection

LabelValue
Developing Habits No.
Type of Treatment Infectious Disease Treatments

FAQs on Laviceftra S 500mg/250mg Injection

Laviceftra S 500mg/250mg Injection may cause allergic reactions and should be avoided by individuals with known cephalosporin allergies. Seek immediate medical attention if you experience symptoms such as hives, difficulty breathing, or swelling of the face, lips, tongue, or throat.
Diarrhea is a possible side effect of Laviceftra S 500mg/250mg Injection. This antibiotic, while targeting harmful bacteria, can also disrupt beneficial gut bacteria, leading to diarrhea. Consult your doctor if you experience severe diarrhea.
Laviceftra S 500mg/250mg Injection typically begins working quickly, though complete bacterial eradication and symptom relief may take several days.
Contact your doctor if your symptoms worsen during treatment or haven't improved after completing the prescribed course.
Continue taking your Laviceftra S 500mg/250mg Injection as prescribed; complete the entire course, even if you feel better. Feeling better doesn't mean the infection is gone.
Laviceftra S 500mg/250mg ...
64
MRP 78
17% off